AMRX vs CZR · P/E 44, rev $1.52B vs rev $5.86B
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) versus Caesars Entertainment Corporation (CZR) — a side-by-side from cached financials, not a winner call.
Amneal Pharmaceuticals, Inc. Class A Common Stock (AMRX) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Caesars Entertainment Corporation (CZR) is a resorts & casinos company listed on US.
Latest reported AMRX revenue for 2026-06-30 was $1.52B. Net income was $119.9M. AMRX currently screens at market cap $5.19B and trailing P/E 44.0.
Latest reported CZR revenue for 2026-06-30 was $5.86B. Net income was -$160.0M. CZR currently screens at market cap $5.95B.
AMRX currently screens at market cap $5.19B and trailing P/E 44.0. CZR currently screens at market cap $5.95B.
Not investment advice. Open the AMRX and CZR stock pages for the full models.
Not investment advice.